Trial Profile
Long-term safety of ezetimibe/simvastatin as compared with simvastatin alone in patients with primary hypercholesterolaemia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Oct 2014
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Ezetimibe; Simvastatin
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- 13 Oct 2014 New trial record